The Travelers Companies
TRV
393.24
+2.63
+0.67%
The Travelers Companies
US · TRV
#295 by market cap
Listed 1991
393.24
+2.63
+0.67%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 5 in the most recent period (2026/Q4).
- Total institutional ownership fell 0.2 percentage points.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 87.17% -0.21pp
- Institutions
- 2,230 -5
- As of
- 2026/Q4 vs. prior period
Holder types
Mutual Fund72.92%
Public Company4.19%
Government Pension Fund3.02%
Hedge Fund2.73%
Private Company1.66%
Sovereign Wealth Fund1.31%
Individual/Insider0.47%
Insurance Company0.45%
Family Office/Trust0.41%
Other12.82%
Top holders as of 2026-09-30
BlackRock
9.63% · 19.74M sh
State Street Global Advisors
7.66% · 15.69M sh
Vanguard Capital Management, LLC
7.23% · 14.82M sh
Vanguard Portfolio Management, LLC
4.00% · 8.19M sh
FMR
3.89% · 7.97M sh
Other
67.68%
Geode Capital Management, LLC
3.07% · 6.28M sh
UBS Asset Management
1.99% · 4.08M sh
Dimensional Fund Advisors
1.78% · 3.64M sh
MFS Investment Management
1.52% · 3.11M sh
Strategic Advisers LLC
1.42% · 2.90M sh
Northern Trust Global Investments
1.38% · 2.82M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 9 buys · 40 sells
| Name | Role | Stake |
|---|---|---|
| Alan Schnitzer | Chairperson & CEO | 0.15% |
| William Heyman | Vice Chairperson | 0.13% |
| Maria Olivo | EVP of Enterprise Risk Management, Reinsurance, Strategic Development & Chief Risk Officer | 0.04% |
| Daniel Yin | Executive VP & Co-Chief Investment Officer | 0.03% |
| Avrohom Kess | Vice Chairman & Chief Legal Officer | 0.02% |
| Michael Klein | Executive VP & President of Personal Insurance | 0.02% |
| David Rowland | Executive VP & Co-Chief Investment Officer | 0.02% |
| Daniel Frey | Chief Financial Officer | 0.01% |
| Andy Bessette | Executive Vice President | 0.01% |
| Gregory Toczydlowski | Executive VP & President of Business Insurance | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-04 | Lesley Goldwasser | Director | Other Acquisition | +280 | $402.89 |
| 2026-11-03 | Maria Olivo | EVP of Enterprise Risk Management, Reinsurance, Strategic Development & Chief Risk Officer | Open Market Disposition | -15,000 | $407.00 |
| 2026-10-27 | Andy Bessette | Executive Vice President | Other Disposition | -25 | -- |
| 2026-10-27 | Andy Bessette | Executive Vice President | Open Market Disposition | -2,999 | $399.35 |
| 2026-10-27 | Andy Bessette | Executive Vice President | Intent to Sell (Form 144) | -3,000 | $399.31 |
| 2026-10-26 | Mojgan Lefebvre | Executive VP, Chief Technology & Operations Officer | Intent to Sell (Form 144) | -11,000 | $393.84 |
| 2026-10-26 | Mojgan Lefebvre | Executive VP, Chief Technology & Operations Officer | Derivative Exercise and Sale | -11,000 | $139.83–393.84 |
| 2026-10-21 | Gregory Toczydlowski | Executive VP & President of Business Insurance | Derivative Exercise and Sale | -34,771 | $140.85–404.43 |
| 2026-10-21 | David Rowland | Executive VP & Co-Chief Investment Officer | Derivative Exercise and Sale | -5,000 | $132.58–405.62 |
| 2026-10-21 | Jeffrey Klenk | Executive VP and President of Bond & Specialty Insurance | Derivative Exercise and Sale | -9,016 | $132.58–405.57 |
| 2026-10-20 | Alan Schnitzer | Chairperson & CEO | Derivative Exercise and Sale | -298,368 | $132.58–398.21 |
| 2026-10-20 | Maria Olivo | EVP of Enterprise Risk Management, Reinsurance, Strategic Development & Chief Risk Officer | Open Market Disposition | -15,100 | $398.44 |
| 2026-10-19 | Michael Klein | Executive VP & President of Personal Insurance | Derivative Exercise and Sale | -7,500 | $139.83–393.26 |
| 2026-09-29 | Elizabeth Beshel E. Robinson | Independent Director | Other Acquisition | +122 | $356.51 |
| 2026-09-29 | Anthony Jabbour | Director | Other Acquisition | +65 | $356.51 |
| 2026-09-29 | Russell Golden | Independent Director | Other Acquisition | +129 | $356.51 |
| 2026-08-27 | Maria Olivo | EVP of Enterprise Risk Management, Reinsurance, Strategic Development & Chief Risk Officer | Open Market Disposition | -6,000 | $369.86 |
| 2026-08-13 | Anthony Jabbour | Director | Other Acquisition | +446 | $370.36 |
| 2026-08-04 | Anthony Jabbour | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-07-27 | William Heyman | Vice Chairperson | Intent to Sell (Form 144) | -2,344 | $398.00 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
The Travelers Companies discussion 0 comments